Want to see DE:HNL full AI Analyst Report?
HNL Stock Chart & Stats
€7.96
-€0.10(-1.26%)
At close: 4:00 PM EDT
€7.96
-€0.10(-1.26%)
Day’s Range― - ―
52-Week Range€6.48 - €10.40
Previous CloseN/A
Volume1.49K
Average Volume (3M)6.13K
Market Cap
€47.65M
Enterprise Value€91.45
Total Cash (Recent Filing)€7.04M
Total Debt (Recent Filing)€48.01M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding6,062,930
10 Day Avg. Volume3,193
30 Day Avg. Volume6,130
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)0.65
Price to Sales (P/S)0.53
P/FCF Ratio15.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.13
Revenue Forecast (FY)€94.50M
Bulls Say, Bears Say
Bulls Say
Improving Cash GenerationPositive and rising TTM operating and free cash flow represent a durable improvement in internal funding. Stronger FCF supports maintenance of installed bases, modest reinvestment, service capacity and reduces reliance on external financing, helping sustain operations over coming quarters.
Manageable LeverageA debt-to-equity near 0.63 with stable leverage gives the company structural financial flexibility. With equity still meaningful, Hönle can fund working capital and selective capex without extreme refinancing pressure, increasing resilience through industrial cycles.
Recurring, Diversified Revenue MixA business model combining equipment sales and recurring consumables/parts plus measurement and adhesive services creates sticky, repeat revenue tied to an installed base. This structural mix supports predictable aftermarket sales and cross-sell opportunities over multiple quarters.
Bears Say
Multi-year Revenue DeclinePersistent top-line shrinkage erodes operating scale and makes fixed-cost absorption harder. Over multiple quarters this weakens margin recovery prospects, constrains reinvestment and risks installed-base replacement demand if underlying end-markets remain muted.
Negative Returns On EquityA negative ROE indicates the company is not generating sufficient profit from shareholder capital. Persistently negative ROE undermines the ability to compound returns, limits retained-earnings growth and raises the bar for operational turnaround to restore capital efficiency.
Limited Debt-cover By Cash FlowOperating cash flow equal to ~18% of debt constrains rapid deleveraging without sustained profit improvement. While FCF is positive, limited coverage restricts large strategic investments or dividend capacity and leaves reliance on further margin or revenue gains to improve leverage ratios.
Dr. Hoenle AG News
HNL FAQ
What was Dr. Hoenle AG’s price range in the past 12 months?
Dr. Hoenle AG lowest stock price was €6.48 and its highest was €10.40 in the past 12 months.
What is Dr. Hoenle AG’s market cap?
Dr. Hoenle AG’s market cap is €47.65M.
When is Dr. Hoenle AG’s upcoming earnings report date?
Dr. Hoenle AG’s upcoming earnings report date is Aug 18, 2026 which is in 13 days.
How were Dr. Hoenle AG’s earnings last quarter?
Dr. Hoenle AG released its earnings results on May 19, 2026. The company reported €0.11 earnings per share for the quarter, the consensus estimate of €0.11 by €0.
Is Dr. Hoenle AG overvalued?
According to Wall Street analysts Dr. Hoenle AG’s price is currently Overvalued.
Does Dr. Hoenle AG pay dividends?
Dr. Hoenle AG pays a Annually dividend of €0.2 which represents an annual dividend yield of N/A. See more information on Dr. Hoenle AG dividends here
What is Dr. Hoenle AG’s EPS estimate?
Dr. Hoenle AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dr. Hoenle AG have?
Dr. Hoenle AG has 6,062,930 shares outstanding.
What happened to Dr. Hoenle AG’s price movement after its last earnings report?
Dr. Hoenle AG reported an EPS of €0.11 in its last earnings report, expectations of €0.11. Following the earnings report the stock price went up 0.846%.
Which hedge fund is a major shareholder of Dr. Hoenle AG?
Currently, no hedge funds are holding shares in DE:HNL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Hoenle AG Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.44%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-5.37%
Trailing 12-Months
Company Description
Dr. Hoenle AG
Dr. Hönle AG is a global provider specializing in industrial ultraviolet (UV) technologies and related systems, with operations spanning Germany and international markets. The company organizes its business into three main segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives division develops industrial bonding solutions for critical applications within sectors such as consumer electronics, medical technology, optics and opto-electronics, the automotive industry, and glass processing. Its Equipment & Systems segment focuses on developing solutions for the efficient drying of inks and coatings, the precise curing of adhesives and plastics, comprehensive surface disinfection, and advanced solar simulation. Lastly, the Glass & Lamps division manufactures quartz glass tubing and rods, which are vital for the lamp, automotive, semiconductor, and fiber optic cable industries, alongside producing specialized lamps utilized for water purification and the drying of various coatings and adhesives. Founded in 1976, Dr. Hönle AG is headquartered in Munich, Germany.
Technical Analysis
LPKF Laser & Electronics
―
Manz AG
―
MAX Automation
―
Singulus Technologies
―
Suss Microtec
―